Cegedim Sa · EURONEXT:ALCGM
Cegedim Sa — Non-Deal Roadshow (June 2015)
34 slides from Cegedim Sa's roadshow presentation, Jun 9, 2015
Slide 1: Q1 2015 Earnings - Market Update USA
Q1 2015 EARNINGS Market Update - USA June 9-11, 2015
Slide 2: Safe Harbor Statement
SAFE HARBOR STATEMENT This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward-looking statements involve risk and uncertainty. Forward-looking statements represent the compa
Slide 3: IFRS 5
IFRS 5 Cegedim announced on April 1st, 2015, that it had completed the disposal of its CRM and Strategic Data division to IMS Health for an estimated selling price of €396 million. This estimated amount is subject to joint review on the basis of the accounts at March 31, 2015, to be prepared within
Slide 4: Agenda
AGENDA. Business & Strategy Review Q1 2015 Financial Situation 4
Slide 5: Business & Strategy Review
Business & Strategy Review
Slide 6: Cegedim at a Glance
Cegedim at a Glance Q1 2015 Earnings – May 2015 6
Slide 7: Transforming Cegedim
Transforming Cegedim Q1 2015 Earnings – May 2015 7
Slide 8: Q1-2015 Key Takeaways
Q1-2015 Key Takeaways Q1 2015 Earnings – May 2015 8
Slide 9: New Breakdown of Activities by Division
New Breakdown of Activities by Division Q1 2015 Earnings – May 2015 9
Slide 10: Health Insurance, HR & e-services Division Overview
Health Insurance, HR & e-services Division Overview Q1 2015 Earnings – May 2015 10
Slide 11: Changes in Insurance Landscape
Changes in Insurance Landscape Q1 2015 Earnings – May 2015 11
Slide 12: Changes in E-business and HR Management and RNP Activities
Changes in E-business and HR Management and RNP Activities Q1 2015 Earnings – May 2015 12
Slide 13: Healthcare Professionals Division Overview
Healthcare Professionals Division Overview Q1 2015 Earnings – May 2015 13
Slide 14: Changes in Software for Healthcare Professionals
Changes in Software for Healthcare Professionals Q1 2015 Earnings – May 2015 14
Slide 15: Cegelease Division Overview
Cegelease Division Overview Q1 2015 Earnings – May 2015 15
Slide 16: FY Performance by Division
FY Performance by Division Q1 2015 Earnings – May 2015 16
Slide 17: Strategy
Strategy Q1 2015 Earnings – May 2015 17
Slide 18: FY 2015 Outlook Revised Upward
FY 2015 Outlook Revised Upward Q1 2015 Earnings – May 2015 18
Slide 19: Q1 2015 Financial Situation
Q1 2015 Financial Situation
Slide 20: Q1-2015 Revenue Growth
Q1-2015 Revenue Growth Q1 2015 Earnings – May 2015 20
Slide 21: Revenue Breakdown from Continuing Activities
Revenue Breakdown from Continuing Activities Q1 2015 Earnings – May 2015 21
Slide 22: Q1 2015 P&L
Q1 2015 P&L Q1 2015 Earnings – May 2015 22
Slide 23: Q1 2015 Performance by Division
Q1 2015 Performance by Division Q1 2015 Earnings – May 2015 23
Slide 24: Q1-2015 Net Debt Change
Q1-2015 Net Debt Change Q1 2015 Earnings – May 2015 24
Slide 25: Q1-2015 Consolidated Balance Sheet
Q1-2015 Consolidated Balance Sheet Q1 2015 Earnings – May 2015 25
Slide 26: Upgraded to BB-, Positive Outlook
Upgraded to BB-, Positive Outlook Q1 2015 Earnings – May 2015 26
Slide 27: IMS Health Transaction Completed on April 1st
IMS Health Transaction Completed on April 1st Q1 2015 Earnings – May 2015 27
Slide 28: Strategic Priorities
Strategic Priorities Q1 2015 Earnings – May 2015 28
Slide 29: Next Events
Next Events Q1 2015 Earnings – May 2015 29
Slide 30: Annexes
Annexes
Slide 31: Revenue & Organic Growth Calculation
Revenue & Organic Growth Calculation Health Healthcare Activities not Q1-2015 Insurance, HR & Cegelease Group Professionals allocated e-services Q1 2014 Revenue a 49,801 36,906 25,867 796 113,370 Impact of disposals 0 0 0 0 0 Q1 2014 Revenue before impact of disposals 49,801 36,906 25,867 796 113,37
Slide 32: Cegedim is Well-Positioned
Cegedim is Well-Positioned Q1 2015 Earnings – May 2015 32
Slide 33: 2015 Financial Agenda
2015 Financial Agenda Q1 2015 Earnings – May 2015 33
Slide 34: We welcome your questions and comments
We welcome your questions and comments Jan Eryk UMIASTOWSKI Chief Investment Officer - Head of Investor Relations janeryk.umiastowski@cegedim.com